ReviewNeuropsychology review2026
Immersive Virtual Reality in Neuropsychological Assessment of Acquired Brain Injury: a Systematic Review and Meta-Analysis.
Review in Neuropsychology review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Acquired brain injury (ABI) often results in a range of cognitive, emotional, and behavioural impairments that compromise everyday functioning. Accurate neuropsychological assessment is essential for developing effective, individualized rehabilitation strategies. However, traditional paper-and-pencil tests frequently lack ecological validity and may underestimate deficits that emerge in complex, real-life contexts. Immersive virtual reality (VR) offers a promising complementary approach by creating interactive, realistic environments that more closely mirror daily cognitive demands. To examine the effectiveness of immersive VR in assessing neurocognitive impairments in ABI populations. Seventeen studies comparing the cognitive performance of ABI patients and healthy controls were analysed, focusing on executive functions, visuospatial abilities, and memory. Healthy controls outperformed ABI patients across all domains. The strongest effect sizes were observed in the visuospatial domain, although results were heterogeneous. Executive function tasks also revealed robust differences with less variability. Memory was the least assessed domain across studies. Moderator analyses indicated that error-based performance measures yielded the largest effect sizes, suggesting they may be particularly informative sensitive in detecting subtle cognitive deficits. In contrast, demographic factors and the inclusion of environmental distractors did not significantly influence outcomes. These findings support immersive VR as a sensitive and ecologically valid tool for neuropsychological assessment in ABI. While the current evidence is promising, further research is required to standardize VR protocols and optimize their clinical application, enabling more personalized and functionally relevant cognitive evaluations.
Indexed as
Identifiers
41995932What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.